ARCHIVES

Also in this 8-page issue: Dept. of Justice, Congress to investigate Merck and FDA actions on Vioxx; FDA asks IOM to study its monitoring system for approved drugs.

This article is from The Cancer Letter archive.

Vol. 30 No. 43 | November 12, 2004

Download PDF Visit The Full Archive

Related Articles

Half of New NCI Funds in FY02 Spent on Grants

November 22, 2002

ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies

June 5, 2009

In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office

July 20, 1990

HCFA Draft Document Dampens Jubilation Over Clinton Plan To Pay Patient Care Costs.

June 16, 2000

RFPs Available, Contract Awards, Sole Source Negotiations

June 25, 1976

Obituary: Sydney Salmon, 63, Founding Director, Arizona Cancer Center

October 15, 1999